- Home
- HOV vs CMRX Comparison
HOV vs CMRX Comparison
Compare HOV & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOV
- CMRX
- Stock Information
- Founded
- HOV 1959
- CMRX 2000
- Country
- HOV United States
- CMRX United States
- Employees
- HOV N/A
- CMRX N/A
- Industry
- HOV Homebuilding
- CMRX Biotechnology: Pharmaceutical Preparations
- Sector
- HOV Consumer Discretionary
- CMRX Health Care
- Exchange
- HOV Nasdaq
- CMRX Nasdaq
- Market Cap
- HOV 843.6M
- CMRX 797.3M
- IPO Year
- HOV N/A
- CMRX 2013
- Fundamental
- Price
- HOV $96.99
- CMRX N/A
- Analyst Decision
- HOV Sell
- CMRX Hold
- Analyst Count
- HOV 2
- CMRX 4
- Target Price
- HOV $155.00
- CMRX $8.51
- AVG Volume (30 Days)
- HOV 90.7K
- CMRX 1.8M
- Earning Date
- HOV 05-21-2025
- CMRX 05-05-2025
- Dividend Yield
- HOV N/A
- CMRX N/A
- EPS Growth
- HOV 18.84
- CMRX N/A
- EPS
- HOV 32.36
- CMRX N/A
- Revenue
- HOV $3,084,345,000.00
- CMRX $212,000.00
- Revenue This Year
- HOV N/A
- CMRX $2,416.04
- Revenue Next Year
- HOV $5.54
- CMRX $923.92
- P/E Ratio
- HOV $2.98
- CMRX N/A
- Revenue Growth
- HOV 8.80
- CMRX N/A
- 52 Week Low
- HOV $81.15
- CMRX $0.75
- 52 Week High
- HOV $240.34
- CMRX $8.55
- Technical
- Relative Strength Index (RSI)
- HOV 47.27
- CMRX 5.34
- Support Level
- HOV $90.95
- CMRX $8.50
- Resistance Level
- HOV $105.00
- CMRX $8.55
- Average True Range (ATR)
- HOV 7.84
- CMRX 0.02
- MACD
- HOV 1.02
- CMRX -1.10
- Stochastic Oscillator
- HOV 58.15
- CMRX 0.00
About HOV Hovnanian Enterprises Inc.
Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations . The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments; Northeast which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia and West Virginia; Southeast which includes Florida, Georgia and South Carolina; and West which includes Arizona, California and Texas. The firm generates maximum revenue from West Segment.
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.